動脈切開術用閉鎖デバイスのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）

当レポートでは、動脈切開術用閉鎖デバイスのパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 動脈切開術用閉鎖デバイス - パイプライン製品：開発段階別
• 動脈切開術用閉鎖デバイス - パイプライン製品：セグメント別
• 動脈切開術用閉鎖デバイス - パイプライン製品：地域別
• 動脈切開術用閉鎖デバイス - パイプライン製品：規制経路別
• 動脈切開術用閉鎖デバイス - パイプライン製品：推定承認日別
• 動脈切開術用閉鎖デバイス - 進行中の臨床試験

第4章 動脈切開術用閉鎖デバイス - 各社の開発中のパイプライン製品

• 動脈切開術用閉鎖デバイス企業 - パイプライン製品：開発段階別
• 動脈切開術用閉鎖デバイス - パイプライン製品：開発段階別

第5章 動脈切開術用閉鎖デバイスの企業と製品の概要

• Aporo Biomedical, Inc.（休止中）：企業の概要
  • Aporo Biomedical, Inc.（休止中）：パイプライン製品と進行中の臨床試験の概要
• Arterica Inc：企業の概要
  • Arterica Inc：パイプライン製品と進行中の臨床試験の概要
• CardioDex Ltd（休止中）：企業の概要
  • CardioDex Ltd（休止中）：パイプライン製品と進行中の臨床試験の概要
• CaveoMed GmbH：企業の概要
  • CaveoMed GmbH：パイプライン製品と進行中の臨床試験の概要
• CloSys Corp：企業の概要
  • CloSys Corp：パイプライン製品と進行中の臨床試験の概要
• CPC of America Inc：企業の概要
  • CPC of America Inc：パイプライン製品と進行中の臨床試験の概要
• CyndRX LLC：企業の概要
  • CyndRX LLC：パイプライン製品と進行中の臨床試験の概要
• Dextera Surgical Inc：企業の概要
  • Dextera Surgical Inc：パイプライン製品と進行中の臨床試験の概要
• Genesis MedTech International Pvt Ltd：企業の概要
  • Genesis MedTech International Pvt Ltd：パイプライン製品と進行中の臨床試験の概要
• Harvard University：企業の概要
  • Harvard University：パイプライン製品と進行中の臨床試験の概要
• Lepu Medical Technology (Beijing) Co Ltd：企業の概要
  • Lepu Medical Technology (Beijing) Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Nanjing SealMed Medical Technology Corp Ltd：企業の概要
  • Nanjing SealMed Medical Technology Corp Ltd：パイプライン製品と進行中の臨床試験の概要
• NewMed Medical Co Ltd：企業の概要
  • NewMed Medical Co Ltd：パイプライン製品と進行中の臨床試験の概要
• ProMed Inc：企業の概要
  • ProMed Inc：パイプライン製品と進行中の臨床試験の概要
• Rex Medical LP：企業の概要
  • Rex Medical LP：パイプライン製品と進行中の臨床試験の概要
• Shanghai HeartCare Medical Technology Co Ltd：企業の概要
  • Shanghai HeartCare Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Spiorad Medical Ltd：企業の概要
  • Spiorad Medical Ltd：パイプライン製品と進行中の臨床試験の概要
• Terumo Interventional Systems：企業の概要
  • Terumo Interventional Systems：パイプライン製品と進行中の臨床試験の概要
• University of Rochester：企業の概要
  • University of Rochester：パイプライン製品と進行中の臨床試験の概要
• Vascular Closure Systems Inc：企業の概要
  • Vascular Closure Systems Inc：パイプライン製品と進行中の臨床試験の概要
• Vivasure Medical Ltd.：企業の概要
  • Vivasure Medical Ltd.：パイプライン製品と進行中の臨床試験の概要
• Zylox-Tonbridge Medical Technology Co Ltd：企業の概要
  • Zylox-Tonbridge Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要

第6章 動脈切開術用閉鎖デバイス - 近年の発展

• 2024年4月15日：Vivasure Medical、PerQseal Elite血管閉鎖システムで治療した初の大静脈孔患者を発表
• 2023年12月12日：Vivasure Medical、PerQseal Elite閉鎖デバイスシステムで治療を受けた初の患者を発表
• 2023年11月17日：Teleflex、MANTAデバイス試験に初の患者を登録
• 2023年11月14日：Vivasure Medical、米国の重要な研究に100人目の患者が登録されたことを発表
• 2023年8月29日：Haemonetics、VASCADE血管閉鎖システムの欧州展開を発表

第7章 付録

GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Arteriotomy Closure Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Arteriotomy Closure Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Arteriotomy Closure Devices Overview

3 Products under Development

• 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
• 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment
• 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory
• 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
• 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
• 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials

4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies

• 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
• 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development

5 Arteriotomy Closure Devices Companies and Product Overview

• 5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
  • 5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Arterica Inc Company Overview
  • 5.2.1 Arterica Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 CardioDex Ltd (Inactive) Company Overview
  • 5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 CaveoMed GmbH Company Overview
  • 5.4.1 CaveoMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 CloSys Corp Company Overview
  • 5.5.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 CPC of America Inc Company Overview
  • 5.6.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 CyndRX LLC Company Overview
  • 5.7.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Dextera Surgical Inc Company Overview
  • 5.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Genesis MedTech International Pvt Ltd Company Overview
  • 5.9.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Harvard University Company Overview
  • 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Lepu Medical Technology (Beijing) Co Ltd Company Overview
  • 5.11.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Nanjing SealMed Medical Technology Corp Ltd Company Overview
  • 5.12.1 Nanjing SealMed Medical Technology Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 NewMed Medical Co Ltd Company Overview
  • 5.13.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 ProMed Inc Company Overview
  • 5.14.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Rex Medical LP Company Overview
  • 5.15.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Shanghai HeartCare Medical Technology Co Ltd Company Overview
  • 5.16.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Spiorad Medical Ltd Company Overview
  • 5.17.1 Spiorad Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Terumo Interventional Systems Company Overview
  • 5.18.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 University of Rochester Company Overview
  • 5.19.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Vascular Closure Systems Inc Company Overview
  • 5.20.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Vivasure Medical Ltd. Company Overview
  • 5.21.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
  • 5.22.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Arteriotomy Closure Devices- Recent Developments

• 6.1 Apr 15, 2024: Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
• 6.2 Dec 12, 2023: Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
• 6.3 Nov 17, 2023: Teleflex enrols first patient in MANTA device trial
• 6.4 Nov 14, 2023: Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
• 6.5 Aug 29, 2023: Haemonetics Announces European Expansion for VASCADE Vascular Closure System

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer